These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9750019)

  • 1. Determination of growth fraction and cell density to evaluate the potential growth of human oligodendroglial and astrocytic tumours.
    Gordower L; Decaestecker C; Lopes MB; Camby I; Nagy N; François C; Cras P; Martin JJ; Brotchi J; Kiss R; Salmon I
    J Cancer Res Clin Oncol; 1998; 124(8):427-34. PubMed ID: 9750019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
    Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
    Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
    Kamiya M; Nakazato Y
    Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients.
    Salmon I; Kiss R; Dewitte O; Gras T; Pasteels JL; Brotchi J; Flament-Durand J
    Cancer; 1992 Jul; 70(2):538-46. PubMed ID: 1319820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
    Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
    J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.
    Decaestecker C; Camby I; Nagy N; Brotchi J; Kiss R; Salmon I
    Brain Pathol; 1998 Jan; 8(1):29-38. PubMed ID: 9458164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
    Deckert M; Reifenberger G; Wechsler W
    J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
    Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
    J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
    Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C
    Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative index in astrocytic tumours.
    Rathi KR; Radotra BD; Khosla VK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
    Gupta M; Djalilvand A; Brat DJ
    Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue.
    Hagel C; Stavrou DK
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):313-8. PubMed ID: 10476048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.